While psychedelic research has, to date, largely focused on mathematical modelling and resting-state neuroimaging, cognitive neuroscientists are bringing new rigour to the field through the use...
In a recent study, scientists mapped descriptions of psychedelic experiences to the brains of subjects through gene expression analysis of neurotransmitters, in an effort to understand...
Algernon Pharmaceuticals has announced that its subsidiary, Algernon NeuroScience (AGN Neuro), has dosed the first subject in its Phase 1 clinical study of an intravenous formulation...
Algernon Pharmaceuticals has received approval to conduct a Phase 1 clinical study of an intravenous formulation (IVF) of DMT for the treatment of stroke in the...
Psyched Wellness has announced preliminary data from tests completed by the National Research Council of Canada (NRC) on its extract AME-1.
Algernon Pharmaceuticals is working to complete an intravenous formulation (IVF) that will be used in its Phase 1 DMT study investigating the compound’s efficacy as a...
The hallucinogenic effect of psychedelics may hold much healing potential, but researchers believe that these compounds could be beneficial for brain disorders without hallucinations.
The lion’s mane mushroom has a long and complex history of being used as a supplement as part of a healthy diet.
Researchers have discovered changes in the brain associated with LSD which they say could help gain insights into how the brain generates behaviour.